Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

A Clinton White Jr¹, Christina M Coyle², Vedantam Rajshekhar³, Gagandeep Singh⁴, W Allen Hauser⁵, Aaron Mohanty¹, Hector H Garcia^{6

7}, Theodore E Nash⁸

Affiliations

¹ University of Texas Medical Branch, Galveston, Texas.
² Albert Einstein College of Medicine, Bronx, New York.
³ Christian Medical College, Vellore, India.
⁴ Dayanand Medical College, Ludhiana, India.
⁵ Columbia University, New York, New York.
⁶ Universidad Peruana Cayetano Heredia, Lima, Peru.
⁷ Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
⁸ National Institutes of Health, Bethesda, Maryland.

PMID: 29644966
PMCID: PMC5928844
DOI: 10.4269/ajtmh.18-88751

Practice Guideline

Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

A Clinton White Jr et al. Am J Trop Med Hyg. 2018 Apr.

. 2018 Apr;98(4):945-966.

doi: 10.4269/ajtmh.18-88751.

Authors

A Clinton White Jr¹, Christina M Coyle², Vedantam Rajshekhar³, Gagandeep Singh⁴, W Allen Hauser⁵, Aaron Mohanty¹, Hector H Garcia^{6

7}, Theodore E Nash⁸

Affiliations

¹ University of Texas Medical Branch, Galveston, Texas.
² Albert Einstein College of Medicine, Bronx, New York.
³ Christian Medical College, Vellore, India.
⁴ Dayanand Medical College, Ludhiana, India.
⁵ Columbia University, New York, New York.
⁶ Universidad Peruana Cayetano Heredia, Lima, Peru.
⁷ Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
⁸ National Institutes of Health, Bethesda, Maryland.

PMID: 29644966
PMCID: PMC5928844
DOI: 10.4269/ajtmh.18-88751

No abstract available

PubMed Disclaimer

Figures

**Figure 1.**
Approach and implications to rating the quality of evidence and strength of recommendations using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology (unrestricted use of the figure granted by the U.S. GRADE Network).

See this image and copyright information in PMC

Cited by

Metastatic malignancy masquerading as neurocysticercosis.
DiMarco DE, Hale AJ, Ulano A, Smith LM. DiMarco DE, et al. IDCases. 2019 Jul 11;18:e00596. doi: 10.1016/j.idcr.2019.e00596. eCollection 2019. IDCases. 2019. PMID: 31372339 Free PMC article.
Neurocysticercosis: Current Perspectives on Diagnosis and Management.
Butala C, Brook TM, Majekodunmi AO, Welburn SC. Butala C, et al. Front Vet Sci. 2021 May 10;8:615703. doi: 10.3389/fvets.2021.615703. eCollection 2021. Front Vet Sci. 2021. PMID: 34041288 Free PMC article. Review.
Neurocysticercosis: Clinical Characteristics and Changes from 26 Years of Experience in an University Hospital in Korea.
Son HJ, Kim MJ, Jung KH, Choi S, Jung J, Chong YP, Kim SH, Lee SO, Choi SH, Kim YS, Woo JH, Jung BK, Song H, Chai JY. Son HJ, et al. Korean J Parasitol. 2019 Jun;57(3):265-271. doi: 10.3347/kjp.2019.57.3.265. Epub 2019 Jun 30. Korean J Parasitol. 2019. PMID: 31284349 Free PMC article.
The many facets of disseminated parenchymal brain cysticercosis: A differential diagnosis with important therapeutic implications.
Del Brutto OH, Garcia HH. Del Brutto OH, et al. PLoS Negl Trop Dis. 2021 Nov 18;15(11):e0009883. doi: 10.1371/journal.pntd.0009883. eCollection 2021 Nov. PLoS Negl Trop Dis. 2021. PMID: 34793447 Free PMC article.
The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations.
Abraham A, Bustos JA, Carabin H, de Meijere R, Sahu PS, Rajshekhar V, Singh G, White AC Jr, Chiodini PL, Gabriël S, Homeida M, Nash T, Ngowi B, Zhou XN, Coyle C, Garcia HH, Winkler AS. Abraham A, et al. PLoS Negl Trop Dis. 2021 Mar 31;15(3):e0009193. doi: 10.1371/journal.pntd.0009193. eCollection 2021 Mar. PLoS Negl Trop Dis. 2021. PMID: 33788843 Free PMC article.

See all "Cited by" articles

References

1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ; GRADE Working Group , 2008. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336: 924–926. - PMC - PubMed
1. Coyle CM, et al. 2012. Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis 6: e1500. - PMC - PubMed
1. Garcia HH, Nash TE, Del Brutto OH, 2014. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13: 1202–1215. - PMC - PubMed
1. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, Dickey M, Reynolds S, Stoner JA, 2010. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870. - PMC - PubMed
1. O’Neal SE, Flecker RH, 2015. Hospitalization frequency and charges for neurocysticercosis, United States, 2003–2012. Emerg Infect Dis 21: 969–976. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

Affiliations

Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

Authors

Affiliations

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources